Showing results (801-810 of 907) with videos related to

Sort By:
Pageof 91
Clinical Lung Cancer|January 30, 2017
Superior Treatment Response and In-field Tumor Control in Epidermal Growth Factor Receptor-mutant Genotype of Stage III Nonsquamous Non-Small cell Lung Cancer Undergoing Definitive Concurrent ChemoradiotherapyYu Jin Lim, Ji Hyun Chang, Hak-Jae Kim, et al.
Environmental Science & Technology|January 8, 2015
Toxicity of metal oxide nanoparticles in Escherichia coli correlates with conduction band and hydration energiesChitrada Kaweeteerawat, Angela Ivask, Rong Liu, et al.
Tuberculosis and Respiratory Diseases|March 13, 2018
Increased Risk of Exacerbation in Asthma Predominant Asthma-Chronic Obstructive Pulmonary Disease Overlap SyndromeJisoo Park, Eun Kyung Kim, Mi Ae Kim, et al.
ACS Nano|February 4, 2015
Use of a pro-fibrogenic mechanism-based predictive toxicological approach for tiered testing and decision analysis of carbonaceous nanomaterialsXiang Wang, Matthew C Duch, Nikhita Mansukhani, et al.
ACS Nano|July 23, 2015
Reduction of Acute Inflammatory Effects of Fumed Silica Nanoparticles in the Lung by Adjusting Silanol Display through Calcination and Metal DopingBingbing Sun, Suman Pokhrel, Darren R Dunphy, et al.
Annals of Dermatology|June 18, 2015
Screening for Psoriatic Arthritis in Korean Psoriasis Patients Using the Psoriatic Arthritis Screening Evaluation QuestionnaireHyang-Suk You, Gun-Wook Kim, Hyun-Ho Cho, et al.
Metabolism: Clinical and Experimental|June 9, 2009
Association of white blood cell count with metabolic syndrome in patients undergoing peritoneal dialysisJung Tak Park, Tae Ik Chang, Dong Ki Kim, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 29, 2009
Metabolic syndrome predicts mortality in non-diabetic patients on continuous ambulatory peritoneal dialysisJung Tak Park, Tae Ik Chang, Dong Ki Kim, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 22, 2021
Combination Chemo-Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti-PD-1Xiangsheng Liu, Jinhong Jiang, Yu-Pei Liao, et al.
Blood|August 20, 2005
Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal typeTae Min Kim, Yeon Hee Park, Sang-Yoon Lee, et al.
Pageof 91